Skip to content

Nasal versus oro-nasal mask during High-intensity-NPPV in COPD

Nasal versus oro-nasal mask during High-intensity-NPPV in COPD

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00007741
Enrollment
28
Registered
2015-03-17
Start date
2015-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44.9 J96.11

Interventions

Group 1: Patients receiving High-Intensity-NPPV due to chronic hypercapnic COPD will be ventilated by nasal mask interface over one night. Polysomnographic recordings as well as capillary blood gas an

Sponsors

Lungenklinik Köln-MerheimKliniken der Stadt Köln gGmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: home mechanical ventilation for at least a month ; written consent ; stable state of illness ; stable blood gases (pH > 7,35 on the date) ; underlying condition: COPD GOLD III-IV ; High-Intensity NPPV ; minimal IPAP of 22 mbar

Exclusion criteria

Exclusion criteria: last hospitalization because of acute clinical deterioration during the last month; deafness ; mental retardation ; lack of written consent ; obesity (BMI > 35)

Design outcomes

Primary

MeasureTime frame
sleepefficiency (as sleeptime/bedtime * 100)

Secondary

MeasureTime frame
quality of ventilation defined by alveolar ventilation represented by mean transcutaneous PCO2 and capillary blood gases (pO2, pCO2); acceptence of ventialltion, evaluated by individual questionnaire; leakages meassured by individual questionnaire as well as readout of built-in software of mechanical ventilators, duration of ventilation

Countries

Germany

Contacts

Public ContactJan Hendrik Storre

Lungenklinik MerheimKliniken der Stadt Köln gGmbH

storrej@kliniken-koeln.de+49221890718344

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 15, 2026